A groundbreaking CRISPR-based tool has been developed to analyze cancer cells directly from patients, revealing critical genetic drivers of acute myeloid leukemia (AML). This innovative approach...
An innovative artificial intelligence system developed at Penn Medicine has significantly enhanced the efficiency of patient intake processes. The system, known as coordn8, has tripled the...
